The FRAXopathies: definition, overview, and update

Area of Science:

• Genetics and Molecular Biology
• Neuroscience
• Reproductive Biology

Background:

• Fragile X syndrome (FXS), fragile X tremor ataxia syndrome (FXTAS), and premature ovarian insufficiency (POI) are distinct clinical conditions.
• These disorders share a common genetic link to the folate-sensitive fragile site FRAXA on the X chromosome.

Purpose of the Study:

• To propose a unifying classification for FXS, FXTAS, and POI as 'FRAXopathies'.
• To review the clinical and molecular characteristics of these related disorders.
• To elucidate the pathogenic mechanisms underlying their distinct phenotypes and explore therapeutic strategies.

Main Methods:

• Literature review and synthesis of existing clinical and molecular data.
• Analysis of genotype-phenotype correlations in FRAXA-related disorders.
• Exploration of emerging therapeutic targets and approaches.

Main Results:

• FRAXA site mutations are the underlying cause of FXS, FXTAS, and POI.
• Distinct molecular mechanisms stemming from FRAXA alterations lead to varied clinical presentations.
• Understanding these pathogenic pathways is crucial for developing targeted therapies.

Conclusions:

• A unified classification of 'FRAXopathies' is proposed for disorders linked to the FRAXA site.
• Detailed understanding of molecular pathogenesis is key to differentiating phenotypes.
• Advances in understanding FRAXopathies are paving the way for novel therapeutic interventions.